Cargando…
XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy
XRCC2 has been shown to increase the radioresistance of some cancers. Here, XRCC2 expression was investigated as a predictor of preoperative radiotherapy (PRT) treatment response in locally advanced rectal cancer (LARC). XRCC2 was found to be overexpressed in rectal cancer tissues resected from pati...
Autores principales: | Qin, Chang-Jiang, Song, Xin-Ming, Chen, Zhi-Hui, Ren, Xue-Qun, Xu, Kai-Wu, Jing, Hong, He, Yu-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741669/ https://www.ncbi.nlm.nih.gov/pubmed/26320178 |
Ejemplares similares
-
An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Yeo, Seung-Gu, et al.
Publicado: (2012) -
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy
por: Lorena, Bottarelli, et al.
Publicado: (2018) -
Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma
por: Ling, Chun-Run, et al.
Publicado: (2017) -
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
por: García, Margarita, et al.
Publicado: (2015) -
Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer
por: Craven, I, et al.
Publicado: (2007)